Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Impel Pharmaceuticals Inc (IMPL)

Impel Pharmaceuticals Inc (IMPL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Impel Pharmaceuticals Inc 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119 USA

https://impelpharma.com P: 206-568-1466

Description:

Impel NeuroPharma Inc. is a late-stage pharmaceutical company. It is focused on utilizing its proprietary technology to develop and commercialize transformative therapies for patients suffering from diseases with high unmet medical needs. Impel NeuroPharma Inc. is based in SEATTLE.

Key Statistics

Overview:

Market Capitalization, $K 956
Enterprise Value, $K -11,624
Shares Outstanding, K 23,900
Annual Sales, $ 12,650 K
Annual Net Income, $ -106,310 K
Last Quarter Sales, $ 5,020 K
Last Quarter Net Income, $ -13,810 K
EBIT, $ -71,590 K
EBITDA, $ -69,580 K
60-Month Beta 1.17
% of Insider Shareholders 6.20%
% of Institutional Shareholders 73.88%
Float, K 22,418
% Float 93.80%
Short Volume Ratio 0.21

Growth:

1-Year Return -98.74%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.58 on 11/14/23
Latest Earnings Date 11/13/23
Earnings Per Share ttm -3.13
EPS Growth vs. Prev Qtr -87.10%
EPS Growth vs. Prev Year 55.73%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

IMPL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -127.43%
Profit Margin % -840.40%
Debt/Equity -1.21
Price/Sales 0.10
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -3.87
Interest Coverage -0.36
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar